Phase I pilot study of oxaliplatin, infusional 5-FU, and cetuximab in recurrent or metastatic head and neck cancer.
Jay S. Dalal
No relevant relationships to disclose
Joshua B. Greene
No relevant relationships to disclose
Craig C. Hofmeister
No relevant relationships to disclose
Ann Lau Clark
No relevant relationships to disclose
Joseph Clark
No relevant relationships to disclose